Vascular Endothelial Growth Factor (VEGF)
VEGF is a signaling protein that promotes the growth of new blood vessels (angiogenesis) and is often elevated in various types of cancer.
VEGF is a biomarker that indicates angiogenesis and is often elevated in cancer.
Key facts at a glance
- Units
- pg/mL
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche VEGF, R&D Systems VEGF ELISA
Vascular Endothelial Growth Factor (VEGF) is a crucial protein that stimulates the formation of new blood vessels, a process known as angiogenesis. This process is essential for tumor growth and metastasis, as tumors require an adequate blood supply to grow and spread.
Elevated levels of VEGF are frequently observed in various types of cancer, including breast, lung, and colorectal cancer. Measuring VEGF levels can help in diagnosing cancer and monitoring its progression.
The reference range for VEGF is typically 0–200 pg/mL. Levels above this range may indicate the presence of a tumor or other conditions that stimulate angiogenesis.
Frequently asked questions
What is the normal range for VEGF?
Why is VEGF important in cancer?
Sources
- 1VEGF and CancerSource
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy